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Summary
Introduction Recently, first reports on benefits from 
Enhanced Recovery After Surgery (ERAS) pathway in 
patients undergoing gastric surgery have appeared. It 
seems that maximal reduction of unfavorable surgery-
induced trauma in patients with gastric malignancy via 
ERAS protocol combined with minimally invasive tech-
niques can improve outcomes.
Objective The aim of this study was to determine the 
influence of laparoscopic surgery and ERAS protocol in 
oncological gastric surgery on early outcomes.
Materials and methods Prospective analysis involved 
28 patients (18 female and 10 male) with gastric malig-
nancy who underwent laparoscopic gastric resection 
between 2009 and 2013. Gastric tumors (gastrointestinal 
stromal tumors or adenocarcinoma) were the indication 
for the surgery. A total of 17 patients underwent lapa-
roscopic local excision, and 11 patients with adenocar-
cinoma or multiple neuroendocrine tumors underwent 
laparoscopic D2 total gastrectomy. Perioperative care 
was based on ERAS principles. Length of hospital stay, 
postoperative course, perioperative complications, and 
readmission rates were analyzed.
Results There was one conversion in the gastrectomy 
group. All patients were mobilized on the day of surgery. 
Oral fluids were introduced on day 0 and were well toler-
ated. Full hospital diet was started on day 2 in all patients, 
but was well tolerated in only 18 of them. One postopera-
tive complication requiring reoperation was noted. The 
length of stay after gastrectomy and gastric wedge resec-
tion was 4.6 (2–6) and 3.3 (2–6) days, respectively. No 
readmissions were noted in the entire group.
Conclusions The implementation of ERAS protocol 
to clinical practice in combination with laparoscopy in 
patients with gastric tumors can result in improved post-
operative care quality, shortening of hospital stay, and 
quicker return to normal activity.
Keywords Gastrectomy · Laparoscopy · Fast-track · Gas-
trointestinal stromal tumors · Stomach neoplasms
Introduction
The Enhanced Recovery After Surgery (ERAS) concept of 
multimodal perioperative care was proposed by Henrik 
Kehlet almost 2 decades ago and continues to gain sup-
port among surgeons from all over the world [1]. Its use 
effectively decreases surgery-induced trauma and post-
operative intestinal insufficiency. In addition to appro-
priate analgesia, early postoperative oral feeding and 
mobilization allow for a shortened hospital stay while 
decreasing the number of complications [2]. The ERAS 
protocol is well documented in colorectal surgery by sev-
eral randomized controlled trials, which confirmed its 
effectiveness [3]. Recently, the first reports on benefits 
from this kind of perioperative care in patients undergo-
ing gastric surgery have appeared [4]. In the past years, 
there has been an increase in the number of laparoscopic 
surgeries performed due to gastrointestinal (GI) neo-
plasms. In comparison with open surgery, laparoscopy 
is associated with less postoperative pain, quicker recov-
ery, and better quality of life early after the procedure 
[4, 5]. As in other operations, it is associated with better 
postoperative outcomes when compared with the classi-
cal approach [6]. This is especially important to patients 
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P. Budzyń ski, PhD · A. Zub-Pokrowiecka, PhD · Prof. A. Budzyń ski
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with gastric neoplasms, particularly cancer, who are 
usually in poor general condition—commonly under-
nourished and burdened by neoadjuvant chemotherapy 
and comorbidities. It seems that a maximal reduction 
of unfavorable surgery-induced trauma in this particu-
lar group of patients via the enhanced recovery program 
combined with minimally invasive techniques can result 
in improved outcomes.
Aim
The aim of this study was to analyze patient outcomes 
after minimally invasive surgery for gastric cancer and 
the application of perioperative care according to the 
ERAS protocol.
Materials and methods
The analysis covered all patients who underwent lapa-
roscopic gastric resection due to malignancy between 
August 2009 and November 2013. Inclusion criteria were 
surgery due to gastric malignancy, performed with the 
intention to cure; use of the laparoscopic approach; 
and the patient’s consent to perioperative care accord-
ing to ERAS principles. The group included 28 patients 
(18 female and 10 male). Mean age was 64 years (range: 
39–86 years), and mean body mass index was 27.4 kg/m2 
(range: 16.1–39.1 kg/m2). The characteristics of the stud-
ied group are represented in Table 1.
Indications for surgery were malignant gastric tumors: 
GI stromal tumors (GIST) in 17 patients, adenocarcinoma 
in 10, and multiple neuroendocrine tumors in 1. In total, 
18 gastric wedge resections and 10 gastrectomies with D2 
lymphadenectomy were performed (Table 2).
Preoperative staging (computed tomography, endo-
scopic ultrasound) excluded distant metastases. In 
all patients, histological verification of the tumor was 
achieved preoperatively. In patients with GIST, the 
average tumor size was 3.5  cm (1.5–6  cm). Five of nine 
patients with gastric adenocarcinoma received preop-
erative chemotherapy (ECF protocol—three cycles of 
epirubicin, cisplatin, and 5-fluorouracil). Patients were 
eligible for neoadjuvant treatment if their World Health 
Organization performance status was 0 or 1 and the his-
tologically proven adenocarcinoma of the stomach was 
considered to be stage II or higher, with no evidence 
of distant metastases, or if they had locally advanced 
disease. Preoperative staging was based on computed 
tomography. Of the four patients who had not undergone 
preoperative chemotherapy, two were not submitted to 
neoadjuvant treatment due to the early stage of the dis-
ease, and in the case of two others, chemotherapy was 
contraindicated due to their poor general health.
Operative technique
Gastric wedge resection
After the creation of pneumoperitoneum and introduc-
tion of four trocars, intraoperative gastroscopy was per-
formed to precisely locate the tumor. In case of smaller 
tumors, wedge resection was performed using an Ech-
elon stapler (green color). A running suture would be 
added for stapler line reinforcement. Larger lesions 
were resected with a harmonic scalpel, and the defect 
in the stomach was closed with two layers of running 
suture. None of the patients had intraoperative tumor 
perforation. Specimens were placed in a plastic bag and 
removed through minilaparotomy in the epigastrium. In 
four patients, small tumor size allowed for extraction of 
the specimen through the mouth with the assistance of 
gastroscopy (natural orifice specimen extraction). At the 
end of the surgery, the anastomosis patency test was per-
formed via insufflation by gastroscope. Mean operative 
time was 68 min (40–150 min).
Gastrectomy
After the creation of a pneumoperitoneum, five trocars 
were introduced. The stomach was dissected according 
to all oncological principles to obtain appropriate lymph-
adenectomy. Side-to-side esophagoenterostomy with 
a Roux limb was then performed using a linear stapling 
device, and the anterior wall was closed by two absorb-
able running stitches. Subsequently, entero-enteral 
side-to-side anastomosis was performed with a similar 
technique. The specimen was placed in a plastic bag and 
then removed through minilaparatomy, additionally 
protected with a wound protector. A blue dye leakage test 
of the esophagoenteric anastomosis was performed at 
the end of surgery. In some patients, after hemostasis, a 
drain was left in the area of the duodenal stump.
In one patient with cardiac infiltration involving 6 cm 
of distal esophagus, it was necessary to dissect the larger 
part of the esophagus to allow for an adequate proximal 
resection margin. In another patient with multiple neu-
roendocrine tumors also involving the duodenal bulb, 
the margins of the distal resection were widened.
Table 1 Demographic characteristics of the studied group
Sex Number of 
patients (n)
Mean age 
(years)
Age range 
(years)
Mean body mass 
index (kg/m2)
Female 18 67.9 39–86 27.3
Male 10 63.4 41–77 27.6
Overall 28 64.0 39–86 27.4
Table 2 Types of surgical procedures and indications
Surgical procedure Indication n
Local excision (n = 18) Gastrointestinal stromal tumor 17
Adenocarcinoma  1
D2 gastrectomy (n = 10) Adenocarcinoma  9
Multiple neuroendocrine tumor  1
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Postoperative complications occurred in one patient 
in whom reoperation was required after gastric wedge 
resection, due to problems with the passage of gastric 
contents resulting from stenosis at the suture line. Oral 
fluids were introduced on day 0 and were well tolerated 
in 26 (92.8 %) patients. Intravenous fluids were stopped 
within the first 24 h in 23 (82.1 %) patients. A full hospital 
diet was started on day 2 in all patients; however, it was 
well tolerated in only 18 (64.0 %) of them—in 5 from the 
gastrectomy group and 13 from the local excision group. 
All patients were mobilized (including the patient after 
conversion) within the first 24 h after surgery. Only five 
patients required postoperative doses of morphine dur-
ing the first day after surgery (total dose not exceeding 
20  mg). Urinary catheters were removed on the day of 
surgery in the afternoon in all but the one converted 
patient. There was no urinary retention in the study 
group. Drains in the peritoneal cavity were left in five 
patients after gastrectomy—we removed them on the first 
postoperative day in three cases, while for the remaining 
two patients, the drains were left in because the intraop-
erative blue dye leakage test indicated a need for anasto-
mosis reinforcement with an additional layer of sutures; 
these drains were removed on the second postoperative 
day. The length of the hospital stay in patients after gas-
trectomy and gastric wedge resection was 4.6 (2–6) days 
and 3.3 (2–6) days, respectively. No early postoperative 
complications or readmissions were noted. Histological 
results confirmed preoperative diagnoses in all patients.
Discussion
The most recent data confirm that the oncological quality 
of laparoscopic resection of GISTs is comparable with open 
surgery and provides better postoperative outcomes and a 
lower risk of complications. Thus, many experts agree that 
minimally invasive techniques should be the first-choice 
treatment option in patients with GIST [7–9]. We also know 
that laparoscopy is a safe alternative for patients with gas-
tric adenocarcinoma undergoing gastrectomy [10]. A 
comparison of laparoscopic surgery and open operations 
shows that the number of harvested lymph nodes is simi-
lar regardless of the chosen technique [11–13].
In our study, perioperative care was based on the 
guidelines of the ERAS protocol. It is well known that peri-
operative care of this kind benefits patients after colonic 
resections [14]. ERAS is widely used in bariatric surgery 
and allows for shortening hospital stays after surgical 
procedures, even down to 1 day [15]. Patients undergo-
ing gastric surgery due to malignancy represent a specific 
group. They are commonly burdened by neoadjuvant 
systemic chemotherapy, have numerous comorbidities, 
and are frequently undernourished. All these factors can 
increase the risk of early postoperative complications that 
can postpone adjuvant therapy and worsen overall treat-
ment outcomes. We can reasonably expect a decrease 
in unfavorable surgery-induced trauma through imple-
mentation of the ERAS protocol. Currently, only a few 
Perioperative care
Patients were admitted to the hospital on the day pre-
ceding surgery. On admission, they were provided with 
detailed information on the planned treatment and peri-
operative care. Two hours before the surgery, all patients 
received 400 ml of a carbohydrate-rich drink. Operations 
were performed with the laparoscopic technique. In 20 
patients, minilaparotomy and trocar placement sites were 
postoperatively injected with 0.25 % bupivacaine solution 
(incisions 10  mm and greater in size were injected with 
10  ml of bupivacaine, while smaller incisions with 5  ml 
of bupivacaine solution). In the remaining eight patients, 
transversus abdominis plane block (TAP block) under 
ultrasound guidance was used at the end of the surgery 
(20 ml of 0.25 % bupivacaine solution on each side). Intra-
operatively, the fluid therapy was restricted, and natrium-
rich crystaloids were partially replaced by colloids. All 
patients received prophylaxis for postoperative nausea 
and vomiting through the administration of 8 mg of intra-
venous dexamethasone and 8 mg of ondansetron prior to 
the end of surgery, and supplemental oxygen was admin-
istered postoperatively. No nasogastric tubes were left 
after the surgery. Drains were used only in selected cases 
(not routinely). As patients returned to the ward, oral 
fluid intake was introduced. Intravenous fluid adminis-
tration was ceased if the patient could tolerate oral fluids. 
A single shot of antibiotic was administered for a second 
time on the first postoperative day (cefazoline 2  g). All 
patients were mobilized on the day of surgery. Analgesia 
was based on paracetamol and nonsteroidal anti-inflam-
matory drugs (NSAIDs). In the early postoperative hours, 
morphine could be administered in minimal doses on 
patient’s demand (patient-controlled anesthesia). Upper 
GI contrast X-ray series with water-soluble contrast were 
performed for esophagojejunostomy leakage test on the 
first postoperative day. None of the patients had stenosis 
or anastomotic leakage. Afterward, the diet was expanded 
gradually to a full hospital diet with additional supple-
mentation of protein-rich drinks.
Results
Conversion was necessary in one case because the infiltra-
tion of the tumor could not be assessed. In that particular 
case, total gastrectomy with splenectomy and resection of 
the transverse colon were performed. In another patient, an 
accidental splenic artery injury occurred during dissection 
of neighboring tissues by a Ligasure vessel sealer. The vessel 
was successfully sutured, but due to the suturing delay and 
signs of thrombosis in the vessel, splenectomy had to be per-
formed. There were no intraoperative complications in the 
remaining patients. Mean time of gastrectomy was 233 min 
(160–420 min), and wedge resection, 75 min (35–140 min). 
R0 resection was confirmed in all patients. In the case of D2 
gastrectomy, the mean number of harvested lymph nodes 
was 29.2 (22–36), and to our knowledge, it is comparable 
with results from open surgery in our center.
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topic were found with regard to upper GI surgery. The 
advantage of minimally invasive techniques can be that 
relaparoscopy in the case of suspected bleeding or anas-
tomotic dehiscence is associated with lower complica-
tion risk than relaparotomy [4]. In the described group of 
patients, drains were left in only selected cases. Minimal 
postoperative drainage allowed for their early removal. 
Although we left them in the first few cases, we tend not 
to use them anymore in any uncomplicated surgery.
Analgesia plays a fundamental role in postoperative 
care. Epidural anesthesia is particularly important in the 
case of classical operations, but its use in laparoscopy is 
limited. Increasingly common is the use of trocar place-
ment sites for infiltration with local anesthetic drugs or 
TAP block [29]. Evidence has shown that analgesia based 
on NSAIDs is generally sufficient in the case of laparo-
scopic surgeries [30, 31]. In our opinion, NSAIDs together 
with paracetamol and local anesthesia (especially TAP 
block) can provide full pain control in the first few days 
after surgery. When needed, analgesia can be enhanced 
with small doses of opioids (patient controlled analgesia).
An important element of the ERAS protocol is early 
mobilization [32]. Its importance is well documented in 
the study by Smart et al. [33], which showed that failure of 
early mobilization is one of the most common causes of 
deviation from the ERAS protocol and is associated with 
prolonged hospital stays. Early effective postoperative 
mobilization of patients is possible mainly due to ade-
quate pain control. Similarly, restriction of intravenous 
fluid administration, early removal of the urinary cathe-
ter, and peritoneal drains improve postoperative patients’ 
comfort, leading to earlier postoperative mobilization.
Conclusions
In our opinion, the clinical implementation of the ERAS pro-
tocol in combination with laparoscopy for patients operated 
on due to malignant gastric tumors can result in improved 
postoperative care quality, shortened hospital stays, and a 
faster return to normal activity in the postoperative period.
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publications report improved postoperative outcomes 
in laparoscopic gastric surgery as a result of enhanced 
recovery programs [16]. These publications unambigu-
ously emphasize the shorter hospital stays that result 
from using the protocol, though only a few of them report 
an accompanying lower rate of complications [16].
Although fasting even up to 12 h prior to surgery has 
been a standard practice intended to prevent pulmo-
nary aspiration in elective surgery, recent studies have 
found no scientific support for its effectiveness. A review 
of available studies and clinical observations provided 
robust evidence that reducing preoperative fasting for 
clear fluids to 2 h and solid foods to 6 h does not lead to 
an increase in complication rates. Additionally, admin-
istration of carbohydrate-rich fluids 2–3  h prior to sur-
gery reduces the fasting time, which decreases catabolic 
reaction and reduces insulin resistance in the organism, 
has an overall positive influence on the nitrogen bal-
ance, and also allows for earlier postoperative return of 
GI function [17, 18]. It is also proven to be safe in patients 
with uncomplicated diabetes mellitus type 2 [19].
In the postoperative period, fluid intake can be started 
on the day of the surgery so that on the second postoper-
ative day, patients receive a full semi-liquid diet. In many 
centers, postoperative oral intake tends to be restricted; 
however, there is strong evidence that early postoperative 
enteral feeding (on the day of surgery) reduces postop-
erative catabolism, hastens the return of intestinal func-
tion, and decreases the risk of complications (as well as 
reduces the risk of anastomotic leakage). This was most 
extensively studied in colorectal surgery [20, 21]. There 
are far fewer publications available on similar topics in 
the case of upper GI tract surgery. According to Lassen et 
al. [22], who performed a multicenter randomized control 
trial on upper GI surgery patients, the early introduction 
of a full diet on the first postoperative day was not associ-
ated with a higher complication rate and allowed for a 
reduction in the hospital stay. To sum up, it seems that 
early oral intake, starting with a small amount of mixed 
food or protein-rich drinks, results in faster return of GI 
tract function and reduces the length of the hospital stay. 
Additionally, early enteral feeding allows for the reduc-
tion of postoperative intravenous fluid administration, 
which has positive effect on the return of bowel function 
and lowers the complication rate [23–25]. The presented 
group of patients was allowed to drink up to 800 ml of flu-
ids on the day of the surgery, which partially eliminated 
the need of infusions. No advantage to routine use of 
nasogastric tube has been observed. It did not decrease 
anastomotic dehiscence risk, the number of pulmonary 
complications, or the mortality rate. A meta-analysis by 
Yang et al. [26] including more than 700 patients after 
gastrectomy has shown that leaving of esophageoenteric 
tube prolongs postoperative ileus and the time of the first 
passage of flatus. Additionally, it significantly decreases 
the patient’s postoperative comfort.
Evidence also shows no benefit in the use of drains in 
the case of colorectal surgery, or surgery of the pancreas, 
appendix, or gallbladder [27, 28]. No publications on this 
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